Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:HSCSNASDAQ:IRIXNASDAQ:NXGLNASDAQ:PETV On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeHSCSHeart Test Laboratories$3.96+2.3%$3.27$2.36▼$7.57$4.28M2.61122,431 shs31,324 shsIRIXIRIDEX$0.98-1.0%$1.03$0.78▼$2.58$16.45M0.6947,342 shs134,601 shsNXGLNEXGEL$2.18-3.1%$2.66$1.84▼$5.10$16.69M0.6568,132 shs14,584 shsPETVPetVivo$0.80+5.3%$0.61$0.29▼$0.98$19.39M0.7820,434 shs22,782 shs10 Stocks Set to Soar in Spring 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceHSCSHeart Test Laboratories+3.39%+21.47%+18.56%+7.32%-26.94%IRIXIRIDEX-1.03%-2.97%-19.67%-34.88%-62.16%NXGLNEXGEL-3.11%-9.54%-19.26%-34.34%-6.44%PETVPetVivo+5.28%+4.03%+54.17%+35.59%+22.94%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationHSCSHeart Test Laboratories2.3954 of 5 stars3.55.00.00.00.60.01.3IRIXIRIDEX0.7879 of 5 stars0.04.00.00.02.41.70.0NXGLNEXGEL0.8589 of 5 stars0.05.00.00.00.82.50.0PETVPetVivoN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceHSCSHeart Test Laboratories 3.00Buy$13.00228.28% UpsideIRIXIRIDEX 0.00N/AN/AN/ANXGLNEXGEL 0.00N/AN/AN/APETVPetVivo 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest HSCS, PETV, NXGL, and IRIX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/18/2025HSCSHeart Test LaboratoriesAscendiant Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$15.00 ➝ $14.00(Data available from 5/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookHSCSHeart Test Laboratories$14.70K291.21N/AN/A$11.16 per share0.35IRIXIRIDEX$48.80M0.34N/AN/A$0.59 per share1.66NXGLNEXGEL$10.23M1.63N/AN/A$0.90 per share2.42PETVPetVivo$1.05M18.53N/AN/A($0.03) per share-26.67Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateHSCSHeart Test Laboratories-$6.61M-$7.48N/AN/AN/AN/A-117.76%-84.09%8/4/2025 (Estimated)IRIXIRIDEX-$9.57M-$0.43N/A∞N/A-22.79%-192.95%-33.97%8/6/2025 (Estimated)NXGLNEXGEL-$3.16M-$0.45N/A∞N/A-52.60%-71.19%-34.79%N/APETVPetVivo-$10.95M-$0.45N/A∞N/A-902.82%-4,813.07%-281.78%6/26/2025 (Estimated)Latest HSCS, PETV, NXGL, and IRIX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/13/2025Q1 2025IRIXIRIDEX-$0.10-$0.10N/A-$0.10$12.10 million$11.90 million5/13/2025Q1 2025NXGLNEXGEL-$0.10-$0.09+$0.01-$0.09$2.73 million$2.81 million3/27/2025Q4 2024IRIXIRIDEX-$0.05-$0.05N/A-$0.05$12.80 million$12.70 million3/24/2025Q4 2024NXGLNEXGEL-$0.10-$0.08+$0.02-$0.11$2.99 million$3.04 million3/13/2025Q3 2025HSCSHeart Test Laboratories-$2.53-$2.5722-$0.0422-$2.57N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthHSCSHeart Test LaboratoriesN/AN/AN/AN/AN/AIRIXIRIDEXN/AN/AN/AN/AN/ANXGLNEXGELN/AN/AN/AN/AN/APETVPetVivoN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioHSCSHeart Test Laboratories0.011.721.52IRIXIRIDEX0.551.540.85NXGLNEXGEL0.191.510.93PETVPetVivo0.020.420.47Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipHSCSHeart Test Laboratories17.24%IRIXIRIDEX20.10%NXGLNEXGEL2.21%PETVPetVivo24.55%Insider OwnershipCompanyInsider OwnershipHSCSHeart Test Laboratories1.80%IRIXIRIDEX7.30%NXGLNEXGEL20.55%PETVPetVivo10.84%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableHSCSHeart Test Laboratories101.08 million962,000Not OptionableIRIXIRIDEX12016.79 million15.42 millionOptionableNXGLNEXGEL107.66 million5.10 millionNot OptionablePETVPetVivo2024.23 million19.06 millionNot OptionableHSCS, PETV, NXGL, and IRIX HeadlinesRecent News About These CompaniesPetvivo Holdings, Inc. and PiezoBioMembrane Inc. Announce Master Services Agreement to Jointly Develop Innovative Functional BiomaterialsMay 22 at 8:00 AM | globenewswire.comDIGITAL LANDIA, LLC IN COOPERATION WITH PETVIVO HOLDINGS, INC. UNVEILS REVOLUTIONARY AUTONOMOUS PET AI ECOSYSTEM TRANSFORMING PET CARE WITH SELF-LEARNING MULTI-AGENT AI TECHNOLOGYMay 13, 2025 | globenewswire.comPetVivo Holdings, Inc. Announces Participation in the D. Boral Capital Inaugural Global ConferenceMay 2, 2025 | newsfilecorp.comPETVIVO HOLDING, INC. ANNOUNCES DISTRIBUTION AGREEMENT WITH EQ ESPECIALIDADESApril 16, 2025 | globenewswire.comPetVivo closes Series B Convertible Preferred Stock offeringApril 2, 2025 | markets.businessinsider.comPETVIVO HOLDINGS, INC. ANNOUNCES CLOSE OF SERIES B CONVERTIBLE PREFERRED STOCK OFFERINGMarch 31, 2025 | globenewswire.comPetVivo, Digital Landia announce partnership for Agentic AI solutionsMarch 3, 2025 | markets.businessinsider.comPetvivo Holdings, Inc. and Digital Landia Corp. Announce Groundbreaking Strategic Alliance Agreement to Pioneer Agentic AI for Animal CommunicationMarch 3, 2025 | globenewswire.comPetVivo Holdings Renames Subsidiary to Focus on Animal HealthFebruary 28, 2025 | tipranks.comPetvivo Holdings, Inc. to Exhibit at the Western Veterinary Conference in Las Vegas, NevadaFebruary 19, 2025 | globenewswire.comPetVivo Holdings, Inc.: PetVivo Reports Fiscal Q3 2025 ResultsFebruary 15, 2025 | finanznachrichten.dePetVivo signs exclusive sales, marketing agreement with VetStemFebruary 14, 2025 | markets.businessinsider.comEarnings call transcript: PetVivo Q3 2025 highlights revenue surgeFebruary 14, 2025 | msn.comPetVivo Reports Fiscal Q3 2025 ResultsFebruary 14, 2025 | globenewswire.comPetVivo Signs Exclusive Sales and Marketing Agreement with VetStem for PrecisePRP® Canine and Equine ProductsFebruary 14, 2025 | globenewswire.comPetVivo Holdings announces private sale of sharesFebruary 13, 2025 | msn.comPETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE THIRD QUARTER ENDED DECEMBER 31, 2024February 11, 2025 | globenewswire.comPetVivo Holdings streamlines operations, COO position cutFebruary 6, 2025 | msn.comPetVivo appoints Mike Eldred as commercialization, operations advisorJanuary 28, 2025 | markets.businessinsider.comPetVivo Engages Former Dechra North American President, Mike Eldred as Commercial and Operations AdvisorJanuary 27, 2025 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeHSCS, PETV, NXGL, and IRIX Company DescriptionsHeart Test Laboratories NASDAQ:HSCS$3.96 +0.09 (+2.33%) Closing price 05/23/2025 03:53 PM EasternExtended Trading$3.92 -0.04 (-1.01%) As of 05/23/2025 06:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.IRIDEX NASDAQ:IRIX$0.98 -0.02 (-1.54%) As of 05/23/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.NEXGEL NASDAQ:NXGL$2.18 -0.07 (-3.11%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$2.18 0.00 (0.00%) As of 05/23/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. The company was incorporated in 2009 and is based in Langhorne, Pennsylvania.PetVivo NASDAQ:PETV$0.80 +0.04 (+5.28%) As of 05/23/2025 03:59 PM EasternPetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/19 - 05/23 Turbulence for Joby Shares: What's Behind the Recent Dip? Pfizer's 7.5% Dividend: Income Haven or House of Cards? TJX Stock Price Stumble Is Your Chance to Pick Up a Bargain Advance Auto Parts Jumps on Surprise Earnings Beat Costco Stock at $1K: Dominance or Danger Zone? Williams-Sonoma: A Fundamentally Good Buy On Sale Now Snowflake Breaks Out! Can It Drift Higher in 2025 and Beyond? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
